Table I.
Clinicopathological characteristics in NSCLC patients (n=75).
| Characteristic | Cases | % |
|---|---|---|
| Age (years) | ||
| <60 | 37 | 49.3 |
| ≥60 | 38 | 50.7 |
| Sex | ||
| Male | 42 | 56.0 |
| Female | 33 | |
| Smoking status | ||
| Smoker | 25 | 33.3 |
| Non-smoker | 50 | 66.7 |
| Tumor size | ||
| <5 cm | 31 | 41.3 |
| ≥5 cm | 44 | 58.7 |
| TNM stage | ||
| I+II | 30 | 40.0 |
| III | 45 | 60.0 |
| Lymph node metastasis | ||
| Absent | 43 | 57.3 |
| Present | 32 | 42.7 |
| Pathological type | ||
| Adenocarcinoma | 46 | 61.3 |
| Squamous cell carcinoma | 29 | 39.7 |
| Vital status (at follow-up) | ||
| Alive | 24 | 32.0 |
| Dead | 51 | 68.0 |
| CENPF expression | ||
| Low | 31 | 41.3 |
| High | 44 | 58.7 |
| FOXM1 expression | ||
| Low | 27 | 36.0 |
| High | 48 | 64.0 |
NSCLC, non-small cell lung cancer; CENPF, centromere protein F; FOXM1, Forkhead box M1.